News Extra [these Stories Appear Only On The Web]
WHO pulls two generic AIDS drugs from approved list
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7455.1518-d (Published 24 June 2004) Cite this as: BMJ 2004;328:1518
- Fiona Fleck
- Geneva
In a move that could dent confidence in the generic drugs industry, the World Health Organization (WHO) withdrew two anti-AIDS drugs, lamivudine and zidovudine, from its list of approved medicines after laboratory tests failed to prove they have the same chemical make up as their patented equivalents, Epivir and Retrovir, both made by GlaxoSmithKline.
The WHO said that withdrawing the 150 mg lamivudine and 300mg zidovudine tablets, contained in blister packs of 10 tablets, from the WHO's recommended list was not the same as pulling …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.